Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

RELIEVE HF: Different Patient Selection and Study Design – Should We Expect Different Results?

Presentation TVT 2022

Less Invasive Ventricular Enhancement for HFrEF

Presenter: John Boehmer

June 10, 2022

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

Transcatheter Closure of An Atypical Sinus Venosus Atrial Septal Defect with Mitigation of Pulmonary Vein Compression

Presenter: Nino Mihatov

June 10, 2022

Presentation TVT 2022

The Cardiovalve Trans-septal System: Device Design and Clinical Program Update

Presenter: D. Scott Lim

June 10, 2022

Presentation TVT 2022

The Cephea Trans-septal System: EFS Program Update

Presenter: Vinod H. Thourani

June 10, 2022

Presentation TVT 2022

The SafeCross Trans-septal Crossing System

Presenter: Lauren Sharan Ranard

June 10, 2022

Presentation TVT 2022

The Protaryx™ Trans-septal Crossing System

Presenter: James S. Gammie

June 10, 2022

Presentation TVT 2022

Planning the Trans-septal Puncture: Tailoring Location Based on LAAO Anatomy (With Case Examples)

Presenter: Devi Nair

June 09, 2022

Presentation TVT 2022

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Presenter: Lauren Ranard

June 09, 2022

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

Advertisement

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Less Invasive Ventricular Enhancement for HFrEF

What (Else) Have We Learned From REDUCE-LAP II?

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Transcatheter Closure of An Atypical Sinus Venosus Atrial Septal Defect with Mitigation of Pulmonary Vein Compression

The Cardiovalve Trans-septal System: Device Design and Clinical Program Update

The Cephea Trans-septal System: EFS Program Update

The SafeCross Trans-septal Crossing System

The Protaryx™ Trans-septal Crossing System

Planning the Trans-septal Puncture: Tailoring Location Based on LAAO Anatomy (With Case Examples)

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content